The relative gene expressions of IL-17 and VEGF-A were highly variable in post-COVID-19 patients, but the expressions of IL-6 and IL-12 showed a trend of being upregulated, while the expression of MIP-1A remained at basal levels in 9 out of 23 patients evaluated (Figure 1). This evidence concerns the gene IL6 and COVID-19.